EU fines pharmaceutical giants $22 million PDF  | Print |  E-mail
Written by Associated Press   
Tuesday, 10 December 2013 10:47

AMSTERDAM (AP) — The European Commission has fined pharmaceuticals giants Johnson & Johnson and Novartis a combined $22 million for colluding to delay the entrance of a cheap generic form of a pain killer to the Dutch market.

In a statement, the Commission's antitrust chief, Joaquin Almunia, said the two companies "shockingly deprived patients in the Netherlands, including people suffering from cancer, from access to a cheaper version of this medicine."

The Commission found that after Johnson & Johnson's patent on a patch containing the drug Fentanyl expired in 2005, it paid Novartis to delay launching a generic version. The delay lasted 17 months, and was more profitable for both companies than competing honestly would have been.

J&J's fine was 10.7 million euros ($14.7 million), and Novartis' was 5.5 million euros.


Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Last Updated on Tuesday, 10 December 2013 15:45
 

Front Page Stories

Perrysburg Twp. Man Sentenced to 22 Years for Rape
07/24/2014 | Sentinel-Tribune Staff

A Perrysburg Township man was senteced to more than 22 years in prison after being found guilty Thur [ ... ]


Vigil set for BGSU student
07/24/2014 | Associated Press

CLEVELAND (AP) — A vigil for a Bowling Green State University student who was found dead in Lorain [ ... ]


Other Front Page Articles